Zobrazeno 1 - 10 of 28 pro vyhledávání: '"Shirley Quintana"'
1
Akademický článek
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up
Autor: Jule Vasquez, Rossana Ruiz, Karina Aliaga, Fernando Valencia, Marco Villena, Shirley Quintana, Tatiana Vidaurre, Luis Casanova
Publikováno v: JCO Global Oncology, Vol , Iss 7, Pp 1199-1205 (2021)
PURPOSEMajor progress has occurred in multiple myeloma (MM) treatment in recent years, but this is not seen in low- and middle-income countries.MATERIALS AND METHODSWe retrospectively assessed the efficacy and safety of cyclophosphamide, thalidomide,
Externí odkaz: https://doaj.org/article/40fe7733e4d94cae8b8d109a8dbb7b18
Zobrazit plný text záznamu
2
Akademický článek
Características clínicas y pronóstico de los pacientes con linfoma leucemia de células t del adulto
Autor: Natalia Valdivieso Lama, Carlos Barrionuevo Cornejo, Judith Vidal Ayllon, Luis Casanova Marquez, Claudio Flores Flores, Lourdes López Chavez, Cindy Alcarraz Molina, Rossana Ruiz Mendoza, Shirley Quintana Truyenque
Publikováno v: Oncología, Vol 32, Iss 3 (2022)
Introducción: El objetivo del presente estudio fue determinar las características clínicas y pronóstico de los pacientes con Leucemia/Linfoma de Células T del Adulto (ATL) en el Instituto Nacional de Enfermedades Neoplásicas (INEN) de Perú.
Externí odkaz: https://doaj.org/article/e2c7c809132b4d8d81cd0a27fc3dcf1c
Zobrazit plný text záznamu
5
Manejo de neoplasias oncohematológicas en el contexto de la pandemia de COVID-19: recomendación de expertos
Autor: Carlos Barrionuevo, C. Samanez, Daniela Dueñas, Thanya Runciman, Denisse Castro, Daniel J Enriquez, Sally Rose Paredes, Brady E Beltran, Lourdes Lopez, Rolig Aliaga, Gisely Hijar, Cindy Alcarraz, Jule Vasquez, Yinno Custodio, Shirley Quintana
Publikováno v: Anales de la Facultad de Medicina; Vol. 82 No. 2 (2021)
Anales de la Facultad de Medicina; Vol. 82 Núm. 2 (2021)
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global public health crisis. Many reports indicate disappointing results in cancer patients compared to the general population. Therefore, exper
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710a1726f7e38643ff56c89790ea8b12
https://doi.org/10.15381/anales.v82i2.18838
Zobrazit plný text záznamu
6
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up
Autor: Marco Villena, Tatiana Vidaurre, Shirley Quintana, Fernando Valencia, Karina Aliaga, Luis Casanova, Rossana Ruiz, Jule Vasquez
Publikováno v: JCO Global Oncology
PURPOSE Major progress has occurred in multiple myeloma (MM) treatment in recent years, but this is not seen in low- and middle-income countries. MATERIALS AND METHODS We retrospectively assessed the efficacy and safety of cyclophosphamide, thalidomi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3748c384f7a59afebf893532989a9d74
http://europepmc.org/articles/PMC8457778
Zobrazit plný text záznamu
7
P-223: Bortezomib-Thalidomide-Dexamethasone (VTD) as salvage treatment in patients with Multiple Myeloma eligible for transplantation in the real world. Long-term follow-up
Autor: Marco Villena, Jule Vasquez, Shirley Quintana, Tatiana Vidaurre, Cindy Alcarraz
Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S162-S163
Background Peru is a middle-income country with limited options to access to novel therapies in multiple myeloma (MM). Bortezomib has been introduced as salvage treatment a few years ago. In this setting, bortezomib, thalidomide, dexamethasone (VTD)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::340a96998d183accdac8a330fc30b8d1
https://doi.org/10.1016/s2152-2650(21)02350-8
Zobrazit plný text záznamu
8
P-183: Clinical characteristics and outcomes in Multiple Myeloma patients younger than 40 years in a non-Caucasian population
Autor: Jule Vasquez, Tatiana Vidaurre, Shirley Quintana
Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S137-S138
Background Multiple Myeloma has a median age at diagnosis of 65 years old. The percentage of patients diagnosed under 40 years old is relatively rare (2,2%) (1, 2). Clinical characteristics about this age group of patients was studied mainly in Cauca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::397d825975cef638959dd68e2cb0c977
https://doi.org/10.1016/s2152-2650(21)02310-7
Zobrazit plný text záznamu
9
Implementation of a High-Dose Cytarabine Outpatient Program for Acute Myeloid Leukemia Patients in a Limited-Source Setting
Autor: Johan Espino, Lourdes Lopez, Tatiana Vidaurre, Fátima Jiménez-Mozo, Emperatriz Ortega, Katia Roque, Daniel J Enriquez, Jhoisy Casas, S. Lozano, Gustavo Sandival, Cindy Alcarraz, Nathaly Poma, Melanie Castro-Mollo, Elizabeth Cervantes, Shirley Quintana, Evelyn Espinoza-Morales, Juan C Haro
Publikováno v: Blood. 138:4981-4981
Background: The management of acute myeloid leukemia (AML) patients usually requires long inpatient treatments that can affect the limited care facilities, the quality of life, and increases healthcare costs. Additionally, leukemia treating centers i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2906f9baeac91815a7e97c0622c9980c
https://doi.org/10.1182/blood-2021-154462
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje